YU46213B - PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate - Google Patents

PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate

Info

Publication number
YU46213B
YU46213B YU118987A YU118987A YU46213B YU 46213 B YU46213 B YU 46213B YU 118987 A YU118987 A YU 118987A YU 118987 A YU118987 A YU 118987A YU 46213 B YU46213 B YU 46213B
Authority
YU
Yugoslavia
Prior art keywords
formula
hydrogen
amino
group
defined above
Prior art date
Application number
YU118987A
Other languages
Serbo-Croatian (sh)
Other versions
YU118987A (en
Inventor
H. Yamashita
M. Oka
J. Okimura
T. Naito
Original Assignee
Bristol-Myers Squibb Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Co. filed Critical Bristol-Myers Squibb Co.
Priority to YU118987A priority Critical patent/YU46213B/en
Publication of YU118987A publication Critical patent/YU118987A/en
Publication of YU46213B publication Critical patent/YU46213B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

POSTUPAK ZA DOBIJANJE 7-/2-(5-AMINO-1,2,4-TIADIAZOL-3-IL)-2-(SUPSTITUISANI)IMINOACETAMIDO/-3 -/3-(KVATERNERNI AMONIO)-1-PROPEN-1-IL/-3-CEFEM-4-KARBOKSILATA formule: u kojoj je R1 vodonik ili amino-zaštitna grupa kao što je tricil; R2 je vodonik, C1-4alkil, C3-6cikloalkil, C3-6cikloalkenil ili grupa formule: gde je R3 vodonik, C1-4 alkil ili karboksi, X je halogen, OH ili C1-4alkoksi i R4 i R5 su svaki nezavisno vodonik, metil ili etil ili R4 i R5, zajedno sa ugljenikovim atomom za koji su vezani, grade C3-5 cikloalkilidenski prsten; i je kvaternerna amonio grupa, i njihovih netoksičnih farmaceutski prihvatljivih soli i estara koji hidrolizuju pod fiziološkim uslovima, naznačen time, što obuhvata reakciju jedinjenja formule: sa kiselinom formule: ili sa njenim aktiviranim derivatom, kao što je hlorid, pri čemu je kao što je definisano gore, R2 ima značenja kao što je definisano gor za R2, ili predstavlja grupu formule: gde su X, R4 i R5 kao što je definisano gore, B1 je karboksi-zaštitna grupa kao što je benzhidril ili t-butil i B2 je vodonik ili amino-zaštitna grupa kao što je tricil, u smeši vode i orgnaskog rastvarača kao što je aceton ili dimetilformamid i na temperaturi od -10 do +50 C, poželjno od +10 C do sobne temperature; što se, po potrebi, vrši uklanjanjem zaštitnih grupa reakcijom sa kiselinom kao što je HCl, i što se dobijeni proizvod formule (I), po potrebi, prevodi u svoju netoksičnu far-maceutski prihvatljivu so ili estar koji hidrolizuje pod fiziološkim uslovima. Prijava sadrži još 2 patentna zahteva.PROCESS FOR PREPARATION 7- / 2- (5-AMINO-1,2,4-THIADIAZOL-3-YL) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL--3-CEPHEM-4-CARBOXYLATE of the formula: wherein R 1 is hydrogen or an amino-protecting group such as tricyl; R 2 is hydrogen, C 1-4 alkyl, C 3-6 cycloalkyl, C 3-6 cycloalkenyl or a group of the formula: wherein R 3 is hydrogen, C 1-4 alkyl or carboxy, X is halogen, OH or C 1-4 alkoxy and R 4 and R 5 are each independently hydrogen, methyl or ethyl or R4 and R5, together with the carbon atom to which they are attached, form a C3-5 cycloalkylidene ring; and is a quaternary ammonio group, and their non-toxic pharmaceutically acceptable salts and esters which hydrolyze under physiological conditions, comprising reacting a compound of formula: with an acid of formula: or with an activated derivative thereof, such as chloride, wherein such as as defined above, R 2 has the meaning as defined above for R 2, or represents a group of the formula: wherein X, R 4 and R 5 are as defined above, B 1 is a carboxy-protecting group such as benzhydryl or t-butyl and B2 is hydrogen or an amino-protecting group such as tricyl, in a mixture of water and an organic solvent such as acetone or dimethylformamide and at a temperature of -10 to +50 C, preferably from +10 C to room temperature; which is optionally carried out by deprotection by reaction with an acid such as HCl, and the resulting product of formula (I) is optionally converted into its non-toxic pharmaceutically acceptable salt or ester which hydrolyzes under physiological conditions. The application contains 2 more patent claims.

YU118987A 1984-04-09 1987-06-25 PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate YU46213B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU118987A YU46213B (en) 1984-04-09 1987-06-25 PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09
YU60085A YU46151B (en) 1984-04-09 1985-04-09 PROCESS FOR OBTAINING 7- / 2- (5-AMINO-1,2,4-THIADIAZOL-3-YL) -2- (SUBSTITUTED) IMINOACETAMIDO / 3- / 3- (QUATERNARY AMMONIO) -1-PROPEN-1-YL / -3-cephem-4-carboxylate
YU118987A YU46213B (en) 1984-04-09 1987-06-25 PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate

Publications (2)

Publication Number Publication Date
YU118987A YU118987A (en) 1988-10-31
YU46213B true YU46213B (en) 1993-05-28

Family

ID=24393575

Family Applications (2)

Application Number Title Priority Date Filing Date
YU60085A YU46151B (en) 1984-04-09 1985-04-09 PROCESS FOR OBTAINING 7- / 2- (5-AMINO-1,2,4-THIADIAZOL-3-YL) -2- (SUBSTITUTED) IMINOACETAMIDO / 3- / 3- (QUATERNARY AMMONIO) -1-PROPEN-1-YL / -3-cephem-4-carboxylate
YU118987A YU46213B (en) 1984-04-09 1987-06-25 PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU60085A YU46151B (en) 1984-04-09 1985-04-09 PROCESS FOR OBTAINING 7- / 2- (5-AMINO-1,2,4-THIADIAZOL-3-YL) -2- (SUBSTITUTED) IMINOACETAMIDO / 3- / 3- (QUATERNARY AMMONIO) -1-PROPEN-1-YL / -3-cephem-4-carboxylate

Country Status (31)

Country Link
JP (4) JPS615084A (en)
KR (1) KR870002166B1 (en)
AR (1) AR244694A1 (en)
AT (1) AT388735B (en)
AU (2) AU580990B2 (en)
BE (1) BE902148A (en)
CA (3) CA1276929C (en)
CH (1) CH669197A5 (en)
DD (3) DD249024A5 (en)
DE (1) DE3512225A1 (en)
DK (1) DK155985A (en)
ES (4) ES8607318A1 (en)
FI (1) FI84830C (en)
FR (1) FR2563832B1 (en)
GB (3) GB2157293B (en)
GR (1) GR850883B (en)
HU (2) HU193750B (en)
IE (2) IE58408B1 (en)
IL (1) IL74826A (en)
IT (1) IT1190353B (en)
LU (1) LU85840A1 (en)
MY (1) MY101940A (en)
NL (1) NL192925C (en)
NZ (1) NZ211659A (en)
OA (1) OA07985A (en)
PT (1) PT80246B (en)
RU (1) RU2056425C1 (en)
SE (4) SE466205B (en)
SU (4) SU1436882A3 (en)
YU (2) YU46151B (en)
ZA (1) ZA852236B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (en) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd Novel cephem compound and preparation thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
DE3650157T2 (en) * 1985-12-26 1995-05-04 Eisai Co Ltd CEPHALOSPORINE COMPOUNDS.
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
JPH085897B2 (en) * 1986-11-06 1996-01-24 エーザイ株式会社 3-propenyl cephem derivative
FR2622585B1 (en) * 1987-11-03 1991-04-19 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A SUBSTITUTED VINYL RADICAL, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED
CN1022837C (en) * 1988-03-16 1993-11-24 卫材株式会社 Process for preparation of cephem derivatives and intermediates therefor
JPH0699449B2 (en) * 1988-03-16 1994-12-07 エーザイ株式会社 Synthetic intermediate of cephem derivative
FR2655042B1 (en) * 1989-11-29 1994-01-21 Adir Cie NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2663332B1 (en) * 1990-06-15 1997-11-07 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A RADICAL PROPENYL SUBSTITUTED BY A QUATERNARY AMMONIUM, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (en) * 1991-08-21 1993-06-25 Biochemie Gmbh NEW PROCESS AND NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
JPH0741484A (en) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk Cephem compound and antimicrobial agent
US5661144A (en) * 1994-08-16 1997-08-26 Meiji Seika Kabushiki Kaisha Cephem derivatives with 3-substituted bis heterocycles
ID28433A (en) 1998-06-22 2001-05-24 Hoffmann La Roche PROPENIL SEFALOSPORIN DEPOSITS
JP4658806B2 (en) 2003-09-09 2011-03-23 日本化学工業株式会社 Method for producing 3-chloromethyl-3-cephem derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (en) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (en) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (en) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
YU118987A (en) 1988-10-31
CH669197A5 (en) 1989-02-28
FI84830B (en) 1991-10-15
HU193750B (en) 1987-11-30
AU580990B2 (en) 1989-02-09
NL192925C (en) 1998-05-07
YU60085A (en) 1987-12-31
FI84830C (en) 1992-01-27
ES551551A0 (en) 1987-07-01
IE58403B1 (en) 1993-09-22
KR870002166B1 (en) 1987-12-14
DD249024A5 (en) 1987-08-26
SE8901224L (en) 1989-04-06
NZ211659A (en) 1988-11-29
YU46151B (en) 1993-05-28
ATA103985A (en) 1989-01-15
SE8901225L (en) 1989-04-06
SU1375140A3 (en) 1988-02-15
JPS615084A (en) 1986-01-10
PT80246B (en) 1987-10-20
GB2194789A (en) 1988-03-16
IT1190353B (en) 1988-02-16
SE505256C2 (en) 1997-07-21
IL74826A0 (en) 1985-07-31
JPS61143391A (en) 1986-07-01
SE8901225D0 (en) 1989-04-06
SU1367858A3 (en) 1988-01-15
CA1340638C (en) 1999-07-06
AT388735B (en) 1989-08-25
SE8501680D0 (en) 1985-04-03
DK155985A (en) 1985-10-10
ES542013A0 (en) 1986-06-16
DE3512225A1 (en) 1985-10-17
GB2194790B (en) 1988-10-05
FR2563832A1 (en) 1985-11-08
AU610278B2 (en) 1991-05-16
PT80246A (en) 1985-05-01
IL74826A (en) 1990-01-18
AR244694A1 (en) 1993-11-30
JPS61143387A (en) 1986-07-01
SU1487814A3 (en) 1989-06-15
CA1276929C (en) 1990-11-27
GB8721346D0 (en) 1987-10-14
GR850883B (en) 1985-11-25
ZA852236B (en) 1985-11-27
GB2194789B (en) 1988-10-12
NL8501002A (en) 1985-11-01
JPH0262557B2 (en) 1990-12-26
GB2194790A (en) 1988-03-16
ES557060A0 (en) 1987-12-01
ES8800949A1 (en) 1987-12-01
MY101940A (en) 1992-02-15
JPS61143390A (en) 1986-07-01
BE902148A (en) 1985-10-09
NL192925B (en) 1998-01-05
FI851379L (en) 1985-10-10
HUT37622A (en) 1986-01-23
OA07985A (en) 1987-01-31
ES551550A0 (en) 1987-06-01
SE8901224D0 (en) 1989-04-06
GB2157293B (en) 1988-10-05
JPH0351716B2 (en) 1991-08-07
SE466205B (en) 1992-01-13
AU4086285A (en) 1985-10-17
IT8520267A0 (en) 1985-04-05
GB8508846D0 (en) 1985-05-09
ES8607318A1 (en) 1986-06-16
DD236735A5 (en) 1986-06-18
LU85840A1 (en) 1985-12-16
IE58408B1 (en) 1993-09-22
SU1436882A3 (en) 1988-11-07
ES8706155A1 (en) 1987-06-01
FI851379A0 (en) 1985-04-04
JPH0350754B2 (en) 1991-08-02
ES8706694A1 (en) 1987-07-01
GB2157293A (en) 1985-10-23
GB8721347D0 (en) 1987-10-14
SE8501680L (en) 1985-10-10
SE470260B (en) 1993-12-20
AU2504188A (en) 1989-03-02
DK155985D0 (en) 1985-04-03
SE470259B (en) 1993-12-20
CA1340672C (en) 1999-07-20
DD251752A5 (en) 1987-11-25
JPH0357106B2 (en) 1991-08-30
FR2563832B1 (en) 1989-08-18
HU204277B (en) 1991-12-30
KR850007424A (en) 1985-12-04
IE850866L (en) 1985-10-09
DE3512225C2 (en) 1990-02-22
SE8901226L (en) 1989-04-06
RU2056425C1 (en) 1996-03-20
SE8901226D0 (en) 1989-04-06

Similar Documents

Publication Publication Date Title
YU46213B (en) PROCESS FOR PREPARATION 7- / 2- (5-Amino-1,2,4-Thiadiazol-3-yl) -2- (SUBSTITUTED) IMINOACETAMIDO / -3- / 3- (QUATERNARY AMMONIO) -1-PROPENE-1- IL / -3-cephem-4-carboxylate
CA1085822A (en) Cephalosporin compounds
ES2026746A6 (en) Antihypercholesterolemic tetrazole compounds
ES2005746A6 (en) Process for the preparation of aryl-piperidine esters.
ES8706144A1 (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof.
PH25314A (en) New naphthyl derivatives, pharmaceutical compositions containing these compounds , their method of use
SU725553A3 (en) Method of preparing benzyl dichlorovinyldimethylcyclopropanecarboxylates
CA1052810A (en) .omega.-(N-ACYLAMINO) ALKYLPHOSPHORYL ETHANOLAMINES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USES
CS242088A2 (en) Method of 1-cyclopropyl-7-substituted-6-fluor-4-oxo-1,4-dihydroquinoline-3-carboxylic acid's derivatives production
HUT37431A (en) Process for the production of imidazo /1,2-c/pyrimidines and of their salts,as well as of therapeutic preparations containing these compounds as agent
ES8201959A1 (en) A method and intermediates for preparing 3,3'-azo-bis-(6-hydroxy benzoic acid).
IL131177A (en) Process for the preparation of nicotinic acids and esters
YU46433B (en) PROCEDURE FOR PREPARATION OF CONDENSED PYRIMIDINE DERIVATIVES
JPS54106430A (en) Novel preparation of lysophosphatidylcholine analog
NISHIGAKI et al. Synthetic Antibacterials. VI. 7-[1-Substituted 2-(5-nitro-2-furyl) vinyl]-1, 8-naphthyridines
ES8307233A1 (en) Derivatives of 1,4-thiazane-carboxylic acid, preparation and utilization thereof and compositions containing same
ES8506606A1 (en) Process for the preparation of basic oxime ethers
JPS5759896A (en) Production of thiazolineazetidinone derivative
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation
ES8504698A1 (en) 2-Acetidinylacetic acid,its preparation,compositions containing it,and method of sterilising the anthers of a plant.
JPS5527111A (en) Preparation of cephapirin
SE8501540D0 (en) TIMOLOLMELLANPRODUKTER
JPS57144264A (en) 6-fluoro-1,4-dihydro-4-oxocinnoline-3-carboxylic acid derivative
JPS58174374A (en) Thiazolidine derivative
JPS559034A (en) Penem derivative and its preparation